Xiaoxiang Chen

5.9k total citations · 1 hit paper
102 papers, 3.6k citations indexed

About

Xiaoxiang Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoxiang Chen has authored 102 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 35 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in Xiaoxiang Chen's work include Cancer-related molecular mechanisms research (21 papers), Ovarian cancer diagnosis and treatment (19 papers) and MicroRNA in disease regulation (17 papers). Xiaoxiang Chen is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), Ovarian cancer diagnosis and treatment (19 papers) and MicroRNA in disease regulation (17 papers). Xiaoxiang Chen collaborates with scholars based in China, United States and Bangladesh. Xiaoxiang Chen's co-authors include Shukui Wang, Xiangxiang Liu, Yuqin Pan, Kaixuan Zeng, Mu Xu, Huiling Sun, Bangshun He, Bei Pan, Xueni Xu and Tao Xu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Xiaoxiang Chen

99 papers receiving 3.6k citations

Hit Papers

METTL14-mediated N6-methy... 2020 2026 2022 2024 2020 50 100 150 200 250

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaoxiang Chen 2.5k 2.2k 431 256 225 102 3.6k
Yue Jin 1.5k 0.6× 737 0.3× 529 1.2× 268 1.0× 109 0.5× 90 2.7k
Sai‐Wah Tsao 1.0k 0.4× 541 0.3× 385 0.9× 137 0.5× 222 1.0× 32 2.2k
Judith Michels 2.5k 1.0× 966 0.4× 2.0k 4.7× 563 2.2× 198 0.9× 55 4.7k
Wang Ma 1.8k 0.7× 1.2k 0.6× 487 1.1× 294 1.1× 383 1.7× 75 3.2k
Shamit K. Dutta 1.6k 0.6× 565 0.3× 723 1.7× 180 0.7× 198 0.9× 62 2.6k
Hongping Xia 3.2k 1.3× 2.4k 1.1× 683 1.6× 604 2.4× 187 0.8× 97 4.5k
Giuseppe Corona 1.7k 0.7× 503 0.2× 1.1k 2.5× 234 0.9× 185 0.8× 109 3.0k
Jürgen Thomale 1.7k 0.7× 558 0.3× 765 1.8× 138 0.5× 306 1.4× 76 2.8k
Thies Schroeder 2.2k 0.9× 2.2k 1.0× 589 1.4× 344 1.3× 122 0.5× 44 3.9k
Ruud P.M. Dings 2.3k 0.9× 698 0.3× 955 2.2× 344 1.3× 92 0.4× 74 3.7k

Countries citing papers authored by Xiaoxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiang Chen more than expected).

Fields of papers citing papers by Xiaoxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiang Chen. The network helps show where Xiaoxiang Chen may publish in the future.

Co-authorship network of co-authors of Xiaoxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiang Chen. A scholar is included among the top collaborators of Xiaoxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiang Chen. Xiaoxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiahui, Wenwen Guo, Qian Zhao, et al.. (2025). TCGA molecular subtypes in endometriosis-associated ovarian cancer: a systematic review and meta-analysis. Annals of Medicine. 57(1). 2583543–2583543.
2.
Nie, Junjie, Xinwei Liu, Mu Xu, et al.. (2024). GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer. Translational Oncology. 49. 102097–102097. 1 indexed citations
3.
Wang, Yuge, Xiaonan Zhong, Honghao Wang, et al.. (2022). Batoclimab as an add‐on therapy in neuromyelitis optica spectrum disorder patients with acute attacks. European Journal of Neurology. 30(1). 195–203. 13 indexed citations
4.
Ni, Jing, Hao Wen, Xuejun Chen, et al.. (2022). Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instability. BJOG An International Journal of Obstetrics & Gynaecology. 129(S2). 14–22. 13 indexed citations
5.
Chen, Xin, et al.. (2022). Long Non-coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer. Reproductive Sciences. 30(2). 601–614. 5 indexed citations
6.
Ni, Jing, Qian Zhao, Xia Xu, et al.. (2021). The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China. Journal of Ovarian Research. 14(1). 68–68. 6 indexed citations
7.
Xu, Xia, Wenwen Guo, Rui Zhou, et al.. (2021). Case Report: Extragonadal Yolk Sac Tumors Originating From the Endometrium and the Broad Ligament: A Case Series and Literature Review. Frontiers in Oncology. 11. 672434–672434. 4 indexed citations
8.
Ni, Jing, et al.. (2020). Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series. Journal of Ovarian Research. 13(1). 29–29. 8 indexed citations
9.
Zhou, Rui, et al.. (2020). The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial. Journal of Ovarian Research. 13(1). 70–70. 1 indexed citations
10.
Chen, Xiaoxiang, Kaixuan Zeng, Mu Xu, et al.. (2019). P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death and Disease. 10(2). 131–131. 82 indexed citations
11.
Xu, Mu, Xiaoxiang Chen, Lin Kang, et al.. (2019). lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. Journal of Hematology & Oncology. 12(1). 3–3. 161 indexed citations
12.
Sun, Li, Yingying Su, Xiangxiang Liu, et al.. (2018). Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma. Journal of Cancer. 9(15). 2631–2639. 106 indexed citations
13.
Deng, Fei, Xia Xu, Mengmeng Lv, et al.. (2017). Age is associated with prognosis in serous ovarian carcinoma. Journal of Ovarian Research. 10(1). 36–36. 32 indexed citations
14.
15.
Chen, Qianqian, et al.. (2015). Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer. PLoS ONE. 10(4). e0123468–e0123468. 11 indexed citations
16.
Zhang, Qing, Xiaozhi Zhao, Xiaoyu Xu, et al.. (2014). Expression and purification of soluble human cystatin C in Escherichia coli with maltose-binding protein as a soluble partner. Protein Expression and Purification. 104. 14–19. 9 indexed citations
17.
Chen, Xiaoxiang. (2013). Study on diagnostic significance of serum cystatin C in detection of early renal impairment in chemotherapy of patients with cancer. 1 indexed citations
18.
Zhang, Ruijie, Gan Zhang, Qian Zheng, et al.. (2012). Concentrations and spatial distributions of selected quinolones antibiotics in Laizhou Bay and main rivers flowing into the bay. Marine Environmental Science. 31(1). 53–57. 3 indexed citations
19.
Chen, Xiaoxiang. (2006). Investigation of the interaction between adriamycin/adriamycintransferrin and DNA with EB as fluorescence probe. Yaowu fenxi zazhi. 1 indexed citations
20.
Xu, Ling, Jianli Liu, Jingfang Lin, et al.. (2003). Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population. Open Repository and Bibliography (University of Liège). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026